United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

std pharmaceutical products ltd - sodium tetradecyl sulfate - solution for injection - 2mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

std pharmaceutical products ltd - sodium tetradecyl sulfate - solution for injection - 5mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

std pharmaceutical products ltd - sodium tetradecyl sulfate - solution for injection - 10mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

std pharmaceutical products ltd - sodium tetradecyl sulfate - solution for injection - 30mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

std pharmaceutical products ltd - sodium tetradecyl sulfate - solution for injection - 30mg/1ml

Ireland - English - HPRA (Health Products Regulatory Authority)

std pharmaceutical (ireland) limited - sodium tetradecyl sulfate - solution for injection - sodium tetradecyl sulfate

Ireland - English - HPRA (Health Products Regulatory Authority)

std pharmaceutical (ireland) limited - sodium tetradecyl sulfate - solution for injection - sodium tetradecyl sulfate

Ireland - English - HPRA (Health Products Regulatory Authority)

std pharmaceutical (ireland) limited - sodium tetradecyl sulfate - solution for injection - sodium tetradecyl sulfate

Ireland - English - HPRA (Health Products Regulatory Authority)

std pharmaceutical (ireland) limited - sodium tetradecyl sulfate - solution for injection - sodium tetradecyl sulfate

Australia - English - Department of Health (Therapeutic Goods Administration)

intermed medical pty ltd - sodium tetradecyl sulfate, quantity: 10 mg/ml - injection, solution - excipient ingredients: benzyl alcohol; dibasic sodium phosphate dodecahydrate; monobasic potassium phosphate; water for injections; sodium hydroxide - the solution is designed for injection directly into the lumen of the varicose vein and is used as a sclerosant in the treatment of uncomplicated varicose veins of the leg by compression sclerotherapy. the strength of fibrovein selected depends on the size of the veins to be treated. fibrovein 3% is for the treatment of large superficial varicose veins. fibrovein 1% is for the treatment of small varicose veins and the larger venules. minor venules and spider veins (venous flares) should be treated with fibrovein 0.5% or 0.2%. the selection of the incorrect strength particularly in the case of minor venules and spider veins is liable to give risk to adverse reactions.